{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:45:12Z","timestamp":1793810712818,"version":"4.6.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s10067-023-06703-8","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T15:04:45Z","timestamp":1689865485000},"page":"2959-2969","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-0907","authenticated-orcid":false,"given":"H\u00fcseyin","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8143-3048","authenticated-orcid":false,"given":"Gizem","family":"Cengiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5616-5723","authenticated-orcid":false,"given":"Senem","family":"\u015ea\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2058-4413","authenticated-orcid":false,"given":"Yasemin \u00d6zden","family":"Eldemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"issue":"4","key":"6703_CR1","doi-asserted-by":"publisher","first-page":"e0123582","DOI":"10.1371\/journal.pone.0123582","volume":"10","author":"B Michelsen","year":"2015","unstructured":"Michelsen B, Fiane R, Diamantopoulos AP, Soldal DM, Hansen IJW, Sokka T et al (2015) A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis. PloS One 10(4):e0123582. https:\/\/doi.org\/10.1371\/journal.pone.0123582","journal-title":"PloS One"},{"key":"6703_CR2","doi-asserted-by":"publisher","first-page":"117954412210891","DOI":"10.1177\/11795441221089182","volume":"15","author":"SI Taha","year":"2022","unstructured":"Taha SI, Samaan SF, Ibrahim RA, Moustafa NM, El-Sehsah EM, Youssef MK (2022) Can complete blood count picture tell us more about the activity of rheumatological diseases? Clin Med Insights Arthritis Musculoskelet Disord 15:11795441221089182. https:\/\/doi.org\/10.1177\/11795441221089182","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"issue":"5","key":"6703_CR3","first-page":"903","volume":"38","author":"A \u0160u\u0107ur","year":"2020","unstructured":"\u0160u\u0107ur A, Jaji\u0107 Z, Iki\u0107 Matija\u0161evi\u0107 M, Stipi\u0107 Markovi\u0107 A, Flegar D, Luka\u010d N et al (2020) Combined manual and automated immunophenotypisation identified disease-specific peripheral blood immune subpopulations in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Clin Exp Rheumatol 38(5):903\u2013916","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"6703_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s40744-019-00172-9","volume":"6","author":"PJ Mease","year":"2019","unstructured":"Mease PJ, Liu M, Rebello S, Kang H, Yi E, Park Y et al (2019) Comparative disease burden in patients with rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis: data from two Corrona registries. Rheumatol Ther 6(4):529\u2013542. https:\/\/doi.org\/10.1007\/s40744-019-00172-9","journal-title":"Rheumatol Ther"},{"issue":"6","key":"6703_CR5","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s10067-018-4105-3","volume":"37","author":"K Tymms","year":"2018","unstructured":"Tymms K, Littlejohn G, Griffiths H, de Jager J, Bird P, Joshua F et al (2018) Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors. Clin Rheumatol 37(6):1617\u20131623. https:\/\/doi.org\/10.1007\/s10067-018-4105-3","journal-title":"Clin Rheumatol"},{"issue":"1","key":"6703_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-018-1764-z","volume":"20","author":"J Inciarte-Mundo","year":"2018","unstructured":"Inciarte-Mundo J, Ramirez J, Hern\u00e1ndez MV, Ruiz-Esquide V, Cuervo A, Cabrera-Villalba SR et al (2018) Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study. Arthritis Res Ther 20(1):1\u201311. https:\/\/doi.org\/10.1186\/s13075-018-1764-z","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"6703_CR7","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s10067-021-06018-6","volume":"41","author":"H-x Zong","year":"2022","unstructured":"Zong H-x, Xu S-q, Wang J-x, Chu Y-r, Chen K-m, Wang C et al (2022) Presence of subclinical inflammation in axial spondyloarthritis patients with NSAID\/anti-TNF-\u03b1 drug-induced clinical remission. Clin Rheumatol 41(5):1403\u20131412. https:\/\/doi.org\/10.1007\/s10067-021-06018-6","journal-title":"Clin Rheumatol"},{"issue":"10","key":"6703_CR8","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1002\/art.23945","volume":"58","author":"A Brown","year":"2022","unstructured":"Brown A, Conaghan P, Karim Z, Quinn M, Ikeda K, Peterfy C et al (2022) An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 58(10):2958\u20132967. https:\/\/doi.org\/10.1002\/art.23945","journal-title":"Arthritis Rheum"},{"issue":"7","key":"6703_CR9","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1136\/annrheumdis-2016-210424","volume":"76","author":"S Alivernini","year":"2017","unstructured":"Alivernini S, Tolusso B, Petricca L, Bui L, Di Sante G, Peluso G et al (2017) Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission? Ann Rheum Dis 76(7):1228\u20131236. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210424","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"6703_CR10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00296-015-3214-4","volume":"35","author":"C-H Chen","year":"2015","unstructured":"Chen C-H, Chen H-A, Liao H-T, Liu C-H, Tsai C-Y, Chou C-T (2015) The clinical usefulness of ESR, CRP, and disease duration in ankylosing spondylitis: the product of these acute-phase reactants and disease duration is associated with patient\u2019s poor physical mobility. Rheumatol Int 35(7):1263\u20131267. https:\/\/doi.org\/10.1007\/s00296-015-3214-4","journal-title":"Rheumatol Int"},{"issue":"Suppl 1","key":"6703_CR11","doi-asserted-by":"publisher","first-page":"i77","DOI":"10.1136\/ard.2010.140582","volume":"70","author":"PJ Mease","year":"2011","unstructured":"Mease PJ (2011) Psoriatic arthritis: update on pathophysiology, assessment and management. Ann Rheum Dis 70(Suppl 1):i77\u2013i84. https:\/\/doi.org\/10.1136\/ard.2010.140582","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"6703_CR12","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320(13):1360\u20131372. https:\/\/doi.org\/10.1001\/jama.2018.13103","journal-title":"JAMA"},{"issue":"1","key":"6703_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13075-020-02190-3","volume":"22","author":"M Jarlborg","year":"2020","unstructured":"Jarlborg M, Courvoisier DS, Lamacchia C, Martinez Prat L, Mahler M, Bentow C et al (2020) Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis. Arthritis Res Ther 22(1):105. https:\/\/doi.org\/10.1186\/s13075-020-02190-3","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 11","key":"6703_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/acr.20575","volume":"63","author":"J Zochling","year":"2011","unstructured":"Zochling J (2011) Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Arthritis Care Res (Hoboken) 63(Suppl 11):47\u201358. https:\/\/doi.org\/10.1002\/acr.20575","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"6703_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/acr2.11171","volume":"2","author":"JR Greenmyer","year":"2020","unstructured":"Greenmyer JR, Stacy JM, Sahmoun AE, Beal JR, Diri E (2020) DAS28-CRP cutoffs for high disease activity and remission are lower than DAS28-ESR in rheumatoid arthritis. ACR Open Rheumatol 2(9):507\u2013511. https:\/\/doi.org\/10.1002\/acr2.11171","journal-title":"ACR Open Rheumatol"},{"issue":"5","key":"6703_CR16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/annrheumdis-2015-207507","volume":"75","author":"MM Schoels","year":"2016","unstructured":"Schoels MM, Aletaha D, Alasti F, Smolen JS (2016) Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann Rheum Dis 75(5):811\u2013818. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207507","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6703_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.29271\/jcpsp.2021.05.537","volume":"30","author":"M Pamukcu","year":"2021","unstructured":"Pamukcu M, Duran TI (2021) Could C-reactive protein\/Albumin Ratio be an indicator of activation in Axial Spondyloarthritis. J Coll Physicians Surg Pak 30(5):537\u2013541. https:\/\/doi.org\/10.29271\/jcpsp.2021.05.537","journal-title":"J Coll Physicians Surg Pak"},{"issue":"2","key":"6703_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.46497\/ArchRheumatol.2020.7456","volume":"35","author":"I Sunar","year":"2020","unstructured":"Sunar I, Ataman \u015e (2020) Serum C-Reactive Protein\/Albumin ratio in rheumatoid arthritis and its relationship with disease activity, physical function, and quality of life. Arch Rheumatol 35(2):247\u2013253. https:\/\/doi.org\/10.46497\/ArchRheumatol.2020.7456","journal-title":"Arch Rheumatol"},{"key":"6703_CR19","doi-asserted-by":"publisher","first-page":"573","DOI":"10.2147\/IJGM.S351505","volume":"15","author":"L Xue","year":"2022","unstructured":"Xue L, Tao L, Sun H, Wang Y, Zhang Y, Lei N et al (2022) Association Between Blood PLT and RBC Related Indices and Disease Activity in Patients with Rheumatoid Arthritis. Int J Gen Med 15:573\u2013581. https:\/\/doi.org\/10.2147\/IJGM.S351505","journal-title":"Int J Gen Med"},{"issue":"5","key":"6703_CR20","first-page":"1105","volume":"31","author":"A Y\u0131ld\u0131r\u0131m","year":"2015","unstructured":"Y\u0131ld\u0131r\u0131m A, Karabiber M, S\u00fcr\u00fcc\u00fc GD, T\u00fcrkbeyler \u0130H, Karakoyun A, Selkuc MY et al (2015) The changes of mean platelet volume and platelet distribution width in patients with rheumatoid arthritis and their correlation with disease activity. Acta Medica Mediterranea 31(5):1105\u20131111","journal-title":"Acta Medica Mediterranea"},{"key":"6703_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.intimp.2018.07.007","volume":"62","author":"W-m Yang","year":"2018","unstructured":"Yang W-m, Zhang W-h, Ying H-q, Xu Y-m, Zhang J, Min Q-h et al (2018) Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: albumin to fibrinogen ratio and C-reactive protein to albumin ratio. Int Immunopharmacol 62:293\u2013298. https:\/\/doi.org\/10.1016\/j.intimp.2018.07.007","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"6703_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3343\/alm.2019.39.4.345","volume":"39","author":"AY Gasparyan","year":"2019","unstructured":"Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD (2019) The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med 39(4):345\u2013357. https:\/\/doi.org\/10.3343\/alm.2019.39.4.345","journal-title":"Ann Lab Med"},{"issue":"5","key":"6703_CR23","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.semarthrit.2020.07.010","volume":"50","author":"B Garcia-Magall\u00f3n","year":"2020","unstructured":"Garcia-Magall\u00f3n B, Castro-Villegas C, Rosello-Pardo R, Salvador-Oliv\u00e1n JA, Navarro-Comp\u00e1n V (2020) Is the new ASDAS nomenclature in agreement with therapeutic decision making in patients with axial spondyloarthritis? Semin Arthritis Rheum 50(5):854\u2013857. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.07.010","journal-title":"Semin Arthritis Rheum"},{"key":"6703_CR24","doi-asserted-by":"publisher","unstructured":"Thomas K, Lazarini A, Kaltsonoudis E, Drosos A, Papalopoulos I, Sidiropoulos P et al (2020) Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patients. Ther Adv Musculoskelet Dis 12. https:\/\/doi.org\/10.1177\/1759720X20937132","DOI":"10.1177\/1759720X20937132"},{"issue":"10","key":"6703_CR25","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1136\/annrheumdis-2014-205213","volume":"74","author":"E Kneepkens","year":"2015","unstructured":"Kneepkens E, Krieckaert C, Van der Kleij D, Nurmohamed M, van Der Horst-Bruinsma I, Rispens T et al (2015) Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up. Ann Rheum Dis 74(10):1825\u20131829. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205213","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"6703_CR26","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.3390\/jcm10235659","volume":"10","author":"T Gazitt","year":"2021","unstructured":"Gazitt T, Elhija MA, Haddad A, Lavi I, Elias M, Zisman D (2021) Implementation of the treat-to-target concept in evaluation of psoriatic arthritis patients. J Clin Med 10(23):5659. https:\/\/doi.org\/10.3390\/jcm10235659","journal-title":"J Clin Med"},{"issue":"6","key":"6703_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00296-006-0253-x","volume":"27","author":"S-W Lee","year":"2007","unstructured":"Lee S-W, Park M-C, Park Y-B, Lee S-K (2007) Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatol Int 27(6):537\u2013540. https:\/\/doi.org\/10.1007\/s00296-006-0253-x","journal-title":"Rheumatol Int"},{"issue":"4","key":"6703_CR28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/biomedicines10040893","volume":"10","author":"K Bonek","year":"2022","unstructured":"Bonek K, Kuca Warnawin E, Kornatka A, Pleba\u0144czyk M, Burakowski T, Ma\u015bli\u0144ski W et al (2022) Circulating miRNA correlates with lipid profile and disease activity in psoriatic arthritis, rheumatoid arthritis, and ankylosing spondylitis patients. Biomedicines 10(4):893. https:\/\/doi.org\/10.3390\/biomedicines10040893","journal-title":"Biomedicines"},{"issue":"Suppl 2","key":"6703_CR29","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1\u2013ii44. https:\/\/doi.org\/10.1136\/ard.2008.104018","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"6703_CR30","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665\u20132673. https:\/\/doi.org\/10.1002\/art.21972","journal-title":"Arthritis Rheum"},{"issue":"9","key":"6703_CR31","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"issue":"9","key":"6703_CR32","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/1756-185X.12505","volume":"20","author":"O Gezer","year":"2017","unstructured":"Gezer O, Batmaz \u0130, Sariyildiz MA, Sula B, Ucmak D, Bozkurt M et al (2017) Sleep quality in patients with psoriatic arthritis. Int J Rheum Dis 20(9):1212\u20131218. https:\/\/doi.org\/10.1111\/1756-185X.12505","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"6703_CR33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10165-009-0211-z","volume":"19","author":"NS Rosa Neto","year":"2009","unstructured":"Rosa Neto NS, De Carvalho JF, Shoenfeld Y (2009) Screening tests for inflammatory activity: applications in rheumatology. Mod Rheumatol 19(5):469\u2013477. https:\/\/doi.org\/10.1007\/s10165-009-0211-z","journal-title":"Mod Rheumatol"},{"issue":"4","key":"6703_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1590\/S0482-50042009000400008","volume":"49","author":"NS Rosa Neto","year":"2009","unstructured":"Rosa Neto NS, Carvalho JF (2009) The use of inflammatory laboratory tests in rheumatology. Rev Bras Reumatol 49(4):413\u2013430. https:\/\/doi.org\/10.1590\/S0482-50042009000400008","journal-title":"Rev Bras Reumatol"},{"key":"6703_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fmed.2018.00185","volume":"5","author":"CK Orr","year":"2018","unstructured":"Orr CK, Najm A, Young F, McGarry T, Biniecka M, Fearon U et al (2018) The utility and limitations of CRP, ESR and DAS28-CRP in appraising disease activity in rheumatoid arthritis. Front Med (Lausanne) 5:185. https:\/\/doi.org\/10.3389\/fmed.2018.00185","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"6703_CR36","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1245\/s10434-015-4948-7","volume":"23","author":"M Ishizuka","year":"2016","unstructured":"Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Shibuya N, Kubota K (2016) Clinical significance of the C-reactive protein to albumin ratio for survival after surgery for colorectal cancer. Ann Surg Oncol 23(3):900\u2013907. https:\/\/doi.org\/10.1245\/s10434-015-4948-7","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"6703_CR37","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00405-019-05770-5","volume":"278","author":"O Hizli","year":"2021","unstructured":"Hizli O, Cayir S, Coluk Y, Kayabasi S, Yildirim G (2021) The novel indicators of moderate to severe sleep apnea: fibrinogen to albumin ratio vs. CRP to albumin ratio. Eur Arch Otorhinolaryngol 278(3):851\u2013855. https:\/\/doi.org\/10.1007\/s00405-019-05770-5","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"6703_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29228\/tjhealthsport.55675","volume":"3","author":"S U\u011fur","year":"2022","unstructured":"U\u011fur S (2022) C-reactive protein to albumin ratio, albumin to globulin ratio and platelet to lymphocyte ratio in patients with spondyloarthritis. Turk J Health S 3(1):1\u20134. https:\/\/doi.org\/10.29228\/tjhealthsport.55675","journal-title":"Turk J Health S"},{"issue":"4","key":"6703_CR39","doi-asserted-by":"publisher","first-page":"e0175909","DOI":"10.1371\/journal.pone.0175909","volume":"12","author":"M Moeller","year":"2017","unstructured":"Moeller M, Pink C, Endlich N, Endlich K, Grabe H-J, V\u00f6lzke H et al (2017) Mortality is associated with inflammation, anemia, specific diseases and treatments, and molecular markers. PLoS One 12(4):e0175909. https:\/\/doi.org\/10.1371\/journal.pone.0175909","journal-title":"PLoS One"},{"key":"6703_CR40","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2147\/TCRM.S393135","volume":"18","author":"L Li","year":"2022","unstructured":"Li L, Shen Q, Rao S (2022) Association of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio with Diabetic Kidney Disease in Chinese Patients with Type 2 Diabetes: A Cross-Sectional Study. Ther Clin Risk Manag 18:1157\u20131166. https:\/\/doi.org\/10.2147\/TCRM.S393135","journal-title":"Ther Clin Risk Manag"},{"key":"6703_CR41","doi-asserted-by":"publisher","first-page":"6642486","DOI":"10.1155\/2021\/6642486","volume":"2021","author":"Z Zhong","year":"2021","unstructured":"Zhong Z, Huang Y, Liu Y, Chen J, Liu M, Huang Q et al (2021) Correlation between C-reactive protein to albumin ratio and disease activity in patients with axial spondyloarthritis. Dis Markers 2021:6642486. https:\/\/doi.org\/10.1155\/2021\/6642486","journal-title":"Dis Markers"},{"key":"6703_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4103\/ds.ds_42_20","volume":"38","author":"F Kemeriz","year":"2020","unstructured":"Kemeriz F, Tu\u01e7rul B, Tuncer S\u00c7 (2020) C-reactive protein to albumin ratio: Is a new parameter for the disease severity in patients with psoriasis vulgaris? Dermatol Sin 38:199\u2013204. https:\/\/doi.org\/10.4103\/ds.ds_42_20","journal-title":"Dermatol Sin"},{"issue":"2","key":"6703_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3325\/cmj.2022.63.141","volume":"63","author":"T Izci Duran","year":"2022","unstructured":"Izci Duran T, Pamukcu M (2022) Relationship between disease impact scores and C-reactive protein\/albumin ratio in patients with psoriatic arthritis. Croat Med J 63(2):141\u2013147. https:\/\/doi.org\/10.3325\/cmj.2022.63.141","journal-title":"Croat Med J"},{"key":"6703_CR44","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1055\/a-1653-1172","volume":"47","author":"ME Onder","year":"2021","unstructured":"Onder ME, Orucoglu N, Omar F, Canataroglu A (2021) C-Reactive protein-to-Albumin ratio: A novel inflammatory marker and disease activity sign in early rheumatoid arthritis. Akt Rheumatol 47:239\u2013247. https:\/\/doi.org\/10.1055\/a-1653-1172","journal-title":"Akt Rheumatol"},{"key":"6703_CR45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2147\/OARRR.S268668","volume":"12","author":"N Afifi","year":"2020","unstructured":"Afifi N, M Medhat B, Abdelghani AM, Mohamedalihassan HGE, Behiry ME (2020) Value of albumin-fibrinogen ratio and CRP-albumin ratio as predictor marker of disease activity in Egyptian RA patients, correlated with musculoskeletal sonography. Open Access Rheumatol 12:241\u2013248. https:\/\/doi.org\/10.2147\/OARRR.S268668","journal-title":"Open Access Rheumatol"},{"issue":"1","key":"6703_CR46","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12891-021-03973-8","volume":"22","author":"J Wang","year":"2021","unstructured":"Wang J, Su J, Yuan Y, Jin X, Shen B, Lu G (2021) The role of lymphocyte-monocyte ratio on axial spondyloarthritis diagnosis and sacroiliitis staging. BMC Musculoskelet Disord 22(1):86. https:\/\/doi.org\/10.1186\/s12891-021-03973-8","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"6703_CR47","doi-asserted-by":"publisher","first-page":"e23964","DOI":"10.1002\/jcla.23964","volume":"35","author":"J Wu","year":"2021","unstructured":"Wu J, Yan L, Chai K (2021) Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis. J Clin Lab Anal 35(9):e23964. https:\/\/doi.org\/10.1002\/jcla.23964","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"6703_CR48","doi-asserted-by":"publisher","first-page":"7383","DOI":"10.21608\/ejhm.2022.274802","volume":"89","author":"AOK Elfitouri","year":"2022","unstructured":"Elfitouri AOK (2022) Neutrophil-Lymphocyte Ratio and Platelat-Lymphocyte Ratio as Potential Markers of Disease Activity in Patients with Axial Spondyloarthritis. Egypt J Hosp Med 89(2):7383\u20137387. https:\/\/doi.org\/10.21608\/ejhm.2022.274802","journal-title":"Egypt J Hosp Med"},{"issue":"1","key":"6703_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s42358-020-0113-5","volume":"60","author":"MH Al-Osami","year":"2020","unstructured":"Al-Osami MH, Awadh NI, Khalid KB, Awadh AI (2020) Neutrophil\/lymphocyte and platelet\/lymphocyte ratios as potential markers of disease activity in patients with Ankylosing spondylitis: a case-control study. Adv Rheumatol 60(1):13. https:\/\/doi.org\/10.1186\/s42358-020-0113-5","journal-title":"Adv Rheumatol"},{"issue":"1","key":"6703_CR50","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4274\/raed.galenos.2021.49369","volume":"13","author":"D\u015e Ero\u011flu","year":"2021","unstructured":"Ero\u011flu D\u015e, Torgutalp M, Sezer S, Yayla ME, \u00d6zel M, Turgay TM et al (2021) Complete blood count derived haematological parameters do not correlate with disease activity in patients with radiographic axial spondyloarthritis. J Turk Soc Rheumatol 13(1):6\u201311. https:\/\/doi.org\/10.4274\/raed.galenos.2021.49369","journal-title":"J Turk Soc Rheumatol"},{"issue":"1","key":"6703_CR51","doi-asserted-by":"publisher","first-page":"9516","DOI":"10.4081\/dr.2022.9516","volume":"15","author":"HT Nguyen","year":"2022","unstructured":"Nguyen HT, Vo LDH, Pham NN (2022) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study. Dermatol Rep 15(1):9516. https:\/\/doi.org\/10.4081\/dr.2022.9516","journal-title":"Dermatol Rep"},{"issue":"5","key":"6703_CR52","doi-asserted-by":"publisher","first-page":"894","DOI":"10.5455\/annalsmedres.2019.02.074","volume":"26","author":"I An","year":"2021","unstructured":"An I, Ucmak D, \u00d6zt\u00fcrk M, Aksoy M, Y\u0131ld\u0131z \u0130, Ucan E (2021) Neutrophil\/Iymphocyte ratio, platelet\/Iymphocyte ratio, mean platelet volume and C-reactive protein values in psoriatic arthritis patients. Ann Med Res 26(5):894\u2013898. https:\/\/doi.org\/10.5455\/annalsmedres.2019.02.074","journal-title":"Ann Med Res"},{"issue":"6","key":"6703_CR53","doi-asserted-by":"publisher","first-page":"773","DOI":"10.29271\/jcpsp.2022.06.773","volume":"32","author":"AK Dincer","year":"2022","unstructured":"Dincer AK, Sezer S (2022) Systemic immune inflammation index as a reliable disease activity marker in psoriatic arthritis. J Coll Physicians Surg Pak 32(6):773\u2013778. https:\/\/doi.org\/10.29271\/jcpsp.2022.06.773","journal-title":"J Coll Physicians Surg Pak"},{"issue":"7","key":"6703_CR54","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/1756-185X.12582","volume":"18","author":"AU Uslu","year":"2015","unstructured":"Uslu AU, K\u00fc\u00e7\u00fck A, \u015eahin A, Ugan Y, Y\u0131lmaz R, G\u00fcng\u00f6r T et al (2015) Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Int J Rheum Dis 18(7):731\u2013735. https:\/\/doi.org\/10.1111\/1756-185X.12582","journal-title":"Int J Rheum Dis"},{"key":"6703_CR55","doi-asserted-by":"publisher","first-page":"4433141","DOI":"10.1155\/2021\/4433141","volume":"2021","author":"M Li","year":"2021","unstructured":"Li M, Xie L (2021) Correlation between NLR, PLR, and LMR and disease activity, efficacy assessment in rheumatoid arthritis. Evid Based Complement Alternat Med 2021:4433141. https:\/\/doi.org\/10.1155\/2021\/4433141","journal-title":"Evid Based Complement Alternat Med"},{"issue":"4","key":"6703_CR56","doi-asserted-by":"publisher","first-page":"553","DOI":"10.12865\/CHSJ.47.04.11","volume":"47","author":"S Satis","year":"2021","unstructured":"Satis S (2021) New inflammatory marker associated with disease activity in rheumatoid arthritis: the systemic immune-inflammation index. Curr Health Sci J 47(4):553\u2013557. https:\/\/doi.org\/10.12865\/CHSJ.47.04.11","journal-title":"Curr Health Sci J"},{"issue":"5","key":"6703_CR57","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4078\/jrd.2016.23.5.288","volume":"23","author":"KY Kang","year":"2016","unstructured":"Kang KY, Jung J-Y, Ju JH, Park S-H, Hong Y-S (2016) Platelet indices are associated with disease activity scores and the severity of sacroiliitis on magnetic resonance imaging in axial spondyloarthritis patients. J Rheum Dis 23(5):288\u2013296. https:\/\/doi.org\/10.4078\/jrd.2016.23.5.288","journal-title":"J Rheum Dis"},{"issue":"3","key":"6703_CR58","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10067-009-1323-8","volume":"29","author":"F Canpolat","year":"2010","unstructured":"Canpolat F, Akp\u0131nar H, Eskio\u011flu F (2010) Mean platelet volume in psoriasis and psoriatic arthritis. Clin Rheumatol 29(3):325\u2013328. https:\/\/doi.org\/10.1007\/s10067-009-1323-8","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06703-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06703-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06703-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T10:13:35Z","timestamp":1697710415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06703-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["6703"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06703-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"assertion":[{"value":"18 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Erciyes University Clinical Research Ethics Committee (Date: 05 May 2021, Approval Number: 2021\/343). This study was conducted in accordance with the Declaration of Helsinki and written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}